Does N-terminal pro-brain natriuretic peptide add prognostic value to the Mehran risk score for contrast-induced nephropathy and long-term outcomes after primary percutaneous coronary intervention?

[1]  Y. Arbel,et al.  Acute Cardio-Renal Syndrome as a Cause for Renal Deterioration Among Myocardial Infarction Patients Treated With Primary Percutaneous Intervention. , 2015, The Canadian journal of cardiology.

[2]  Jiyan Chen,et al.  Association of N-Terminal Pro-B-Type Natriuretic Peptide With Contrast-Induced Nephropathy and Long-Term Outcomes in Patients With Chronic Kidney Disease and Relative Preserved Left Ventricular Function , 2015, Medicine.

[3]  R. Kiani,et al.  Intravenous magnesium sulfate: new method in prevention of contrast-induced nephropathy in primary percutaneous coronary intervention , 2015, International Urology and Nephrology.

[4]  M. B. Demirçelik,et al.  Association Between N‐Terminal Pro‐Brain Natriuretic Peptide Levels and Contrast‐Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome , 2014, Clinical cardiology.

[5]  L. Correia,et al.  Does C-reactive Protein Add Prognostic Value to GRACE Score in Acute Coronary Syndromes? , 2014, Arquivos brasileiros de cardiologia.

[6]  A. Discacciati,et al.  B-Type Natriuretic Peptide and Risk of Acute Kidney Injury in Patients Hospitalized With Acute Coronary Syndromes* , 2014, Critical care medicine.

[7]  Yibo He,et al.  Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention , 2014, International Urology and Nephrology.

[8]  H. Uyarel,et al.  High BNP level as risk factor for acute kidney injury and predictor of all-cause mortality in STEMI patients , 2013, Herz.

[9]  H. Gurm,et al.  A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention. , 2013, Journal of the American College of Cardiology.

[10]  G. Gensini,et al.  The prognostic role of chronic obstructive pulmonary disease in ST-elevation myocardial infarction after primary angioplasty , 2013, European journal of preventive cardiology.

[11]  J. Wi,et al.  Prediction of Contrast‐Induced Nephropathy With Persistent Renal Dysfunction and Adverse Long‐term Outcomes in Patients With Acute Myocardial Infarction Using the Mehran Risk Score , 2013, Clinical cardiology.

[12]  G. Stone,et al.  B-type Natriuretic Peptide and Risk of Contrast-Induced Acute Kidney Injury in Acute ST-Segment–Elevation Myocardial Infarction: A Substudy from the HORIZONS-AMI Trial , 2012, Circulation. Cardiovascular interventions.

[13]  A. Garg,et al.  Preoperative Serum Brain Natriuretic Peptide and Risk of Acute Kidney Injury After Cardiac Surgery , 2012, Circulation.

[14]  P. Aspelin,et al.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines , 2011, European Radiology.

[15]  J. Wi,et al.  Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention , 2011, Heart.

[16]  A. Colombo,et al.  Impact of contrast-induced acute kidney injury definition on clinical outcomes. , 2011, American heart journal.

[17]  G. Sangiorgi,et al.  Mehran Contrast-Induced Nephropathy Risk Score Predicts Short- and Long-Term Clinical Outcomes in Patients With ST-Elevation–Myocardial Infarction , 2010, Circulation. Cardiovascular interventions.

[18]  P. Armstrong,et al.  Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone concentrations in ST elevation myocardial infarction: An analysis from the ASSENT-4 Percutaneous Coronary Intervention Trial , 2010, Critical care medicine.

[19]  Ari B. Geller,et al.  Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease , 2010, International Urology and Nephrology.

[20]  Rafael Freitas,et al.  Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[21]  T. Iwasaka,et al.  Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. , 2010, The American journal of cardiology.

[22]  H. Gurm,et al.  THE CHANGING DEFINITION OF CONTRAST INDUCED NEPHROPATHY AND ITS CLINICAL IMPLICATIONS: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM (BMC2) , 2010 .

[23]  L. Correia,et al.  Does acute hyperglycemia add prognostic value to the GRACE score in individuals with non-ST elevation acute coronary syndromes? , 2009, Clinica chimica acta; international journal of clinical chemistry.

[24]  Y. Pinto,et al.  Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. , 2009, Journal of the American College of Cardiology.

[25]  R. Ferreira,et al.  Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes? , 2009, Acute cardiac care.

[26]  N. Ohte,et al.  Anemia is an independent predictor for elevated plasma levels of natriuretic peptides in patients undergoing cardiac catheterization for coronary artery disease. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[27]  Eugene Demidenko,et al.  Sample size and optimal design for logistic regression with binary interaction , 2008, Statistics in medicine.

[28]  Song-min Huang,et al.  Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[29]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[30]  G. Stone,et al.  A risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention , 2003 .

[31]  Michael E Matheny,et al.  Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. , 2014, JACC. Cardiovascular interventions.